Patient-derived glioblastoma cultures as a tool for small-molecule drug discovery-Reference-Cited by-同舟云学术

Patient-derived glioblastoma cultures as a tool for small-molecule drug discovery

Published:2020-01-28 Issue:4 Volume:11 Page:443-451
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Ye Ling F.¹,Reznik Eduard¹,Korn Joshua M.²,Lin Fallon²,Yang Guizhi²,Malesky Kimberly²,Gao Hui²,Loo Alice²,Pagliarini Raymond²,Mikkelsen Tom³,Lo Donald C.⁴,deCarvalho Ana C.³,Stockwell Brent R.¹⁵

Affiliation:

1. Department of Biological Sciences, Columbia University, New York, NY 10027, USA

2. Novartis Institutes for BioMedical Research, Cambridge, MA 02139, USA

3. Departments of Neurosurgery, Henry Ford Hospital, Detroit, MI 48202, USA

4. Center for Drug Discovery and Department of Neurobiology, Duke University Medical Center, Durham, NC 27710, USA

5. Department of Chemistry, Columbia University, New York, NY 10027, USA

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of genomic background and developmental state on signaling pathways and response to therapy in glioblastoma patient-derived cells;2024-03-16

2. Glioblastoma preclinical models: Strengths and weaknesses;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2024-01

3. Lessons learned from phase 3 trials of immunotherapy for glioblastoma: Time for longitudinal sampling?;Neuro-Oncology;2023-11-23

4. Non-animal glioblastoma models for personalized treatment;Heliyon;2023-10

5. Ex vivo drug sensitivity screening predicts response to temozolomide in glioblastoma patients and identifies candidate biomarkers;British Journal of Cancer;2023-08-24